Siemens Fonds Invest GmbH Acquires 3,450 Shares of Stryker Co. (NYSE:SYK)

Siemens Fonds Invest GmbH boosted its holdings in Stryker Co. (NYSE:SYK - Free Report) by 23.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 18,349 shares of the medical technology company's stock after purchasing an additional 3,450 shares during the quarter. Siemens Fonds Invest GmbH's holdings in Stryker were worth $6,607,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the business. Elefante Mark B bought a new stake in shares of Stryker during the fourth quarter valued at approximately $337,000. Chicago Capital LLC increased its holdings in shares of Stryker by 3.1% during the fourth quarter. Chicago Capital LLC now owns 195,052 shares of the medical technology company's stock valued at $70,228,000 after acquiring an additional 5,841 shares in the last quarter. Appleton Partners Inc. MA increased its holdings in shares of Stryker by 5.0% during the fourth quarter. Appleton Partners Inc. MA now owns 29,222 shares of the medical technology company's stock valued at $10,521,000 after acquiring an additional 1,400 shares in the last quarter. Metis Global Partners LLC increased its holdings in shares of Stryker by 10.2% during the fourth quarter. Metis Global Partners LLC now owns 16,841 shares of the medical technology company's stock valued at $6,064,000 after acquiring an additional 1,561 shares in the last quarter. Finally, Fred Alger Management LLC increased its holdings in shares of Stryker by 415.8% during the fourth quarter. Fred Alger Management LLC now owns 24,011 shares of the medical technology company's stock valued at $8,664,000 after acquiring an additional 19,356 shares in the last quarter. 77.09% of the stock is currently owned by institutional investors.

Insider Activity

In other news, Director Ronda E. Stryker sold 200,000 shares of the company's stock in a transaction on Tuesday, May 6th. The stock was sold at an average price of $376.96, for a total transaction of $75,392,000.00. Following the transaction, the director now owns 3,417,326 shares of the company's stock, valued at $1,288,195,208.96. This represents a 5.53% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 5.20% of the company's stock.

Stryker Stock Performance

SYK stock traded up $0.51 during midday trading on Friday, hitting $382.86. The company's stock had a trading volume of 1,993,145 shares, compared to its average volume of 1,342,825. The stock's 50-day moving average price is $368.77 and its 200 day moving average price is $376.22. The company has a quick ratio of 1.32, a current ratio of 1.95 and a debt-to-equity ratio of 0.59. Stryker Co. has a 1 year low of $314.93 and a 1 year high of $406.19. The stock has a market cap of $146.13 billion, a price-to-earnings ratio of 49.34, a PEG ratio of 2.93 and a beta of 0.93.

Stryker (NYSE:SYK - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.84 EPS for the quarter, beating analysts' consensus estimates of $2.73 by $0.11. Stryker had a return on equity of 23.58% and a net margin of 13.25%. The firm had revenue of $5.87 billion for the quarter, compared to analysts' expectations of $5.68 billion. During the same quarter in the prior year, the firm earned $2.50 EPS. The business's revenue for the quarter was up 11.9% compared to the same quarter last year. On average, equities analysts forecast that Stryker Co. will post 13.47 EPS for the current year.

Stryker Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, July 31st. Stockholders of record on Monday, June 30th will be given a dividend of $0.84 per share. The ex-dividend date of this dividend is Monday, June 30th. This represents a $3.36 dividend on an annualized basis and a dividend yield of 0.88%. Stryker's dividend payout ratio is presently 45.41%.

Wall Street Analysts Forecast Growth

SYK has been the subject of several recent research reports. Truist Financial boosted their price objective on Stryker from $390.00 to $400.00 and gave the company a "hold" rating in a report on Monday, May 5th. BTIG Research set a $403.00 price target on Stryker and gave the stock a "buy" rating in a report on Monday, April 14th. Needham & Company LLC reiterated a "buy" rating and set a $442.00 price target on shares of Stryker in a report on Friday, March 21st. Argus set a $450.00 price target on Stryker in a report on Monday, February 3rd. Finally, Roth Mkm upped their price target on Stryker from $405.00 to $456.00 and gave the stock a "buy" rating in a report on Friday, May 2nd. Five investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company's stock. Based on data from MarketBeat, Stryker has a consensus rating of "Moderate Buy" and an average price target of $427.30.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.